Summary
Probucol has been used as a lipid-lowering agent for over 10 years. Lately it has been found that its antiatherogenic action is due mainly to its antioxidative capacity, in addition to its known lipid-lowering effect. To study the antioxidative capability of probucol and its influence on plaque developement we used the animal model of the LDL-receptor-defective Watanabe heritable hyperlipidemic (WHHL) rabbit. In this study we measured all lipid values before and after probucol feeding and compared them with corresponding values in untreated controls. Probucol levels were determined, as were the physiological antioxidants alpha and gamma tocopherol (vitamin E). Thiobarbituric reactive substances were measured in plasma as a parameter for lipid peroxidation. In addition to the biochemical measurements the plaque area was analyzed macroscopically and microscopically to check the antiatherosclerotic effect and correlate it with the biochemical parameters. In four experiments we showed that probucol treatment in WHHL rabbits decreases the progression of atherosclerotic plaques by way of a combined lipid-lowering and antioxidative effect.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Yamamoto A, Matsuzawa Y, Yokoyama S, Funahashi T, Yamamura T, Kishino B (1986) Effects of probucol on xanthomata regression in familial hypercholesterolemia. Am J Cardiol 57: 29H-35H
Parthasarathy S, Young S, Witztum J, Pittman R, Steinberg D (1986) Probucol inhibits oxidative modification of low density lipoprotein.J Clin Invest 77: 641–644
Goldberg RB, Mendez A (1988) Probucol enhances cholesterol efflux from cultured human skin fibroblasts. Am J Cardiol 62: 57B-59B
Watanabe Y (1980) Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL rabbit). Atherosclerosis 36: 261–268
Kita T, Brown MS, Watanabe Y, Goldstein JL (1981) Deficiency of low density lipoprotein receptors in liver and adrenal gland of WHHL rabbits, an animal model of familial hypercholesterolemia. Proc Natl Acad Sci USA 78: 2268–2272
Satonin D, Coutant J (1986) Comparison of gas chromatography and high performance liquid chromatography for the analysis of probucol in plasma. J Chromatogr 380: 401–406
Catignani G (1986) An HPLC method for the simultaneous determination of retinol and alpha-tocopherol in plasma or serum. Methode Enzymol 123: 215–219
Hunter M, Mohamed B (1986) Plasma antioxidants and lipid peroxidation products in Duchenne muscular dystrophy. Clin Chim Acta 155: 123–132
Kita T, Nagano Y, Yokode M, et al. (1987) Probucol prevents the progression of atherosclerosis in WHHL rabbits, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci USA 84: 5928–5931
Carew TE, Schwenke DC, Steinberg D (1987) Antiatherogenic effect of probucol is unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit LDL degradation in macrophage-rich fatty streaks and slow down the progression of atherosclerosis in WHHL rabbit. Proc Natl Acad Sci USA 84: 7725–7729
Author information
Authors and Affiliations
Additional information
This article is based in part on the doctoral study performed by Barbara Finckh in the Faculty of Biology, University of Hamburg
Rights and permissions
About this article
Cite this article
Finckh, B., Niendorf, A., Rath, M. et al. Antiatherosclerotic effect of probucol in WHHL rabbits: Are there plasma parameters to evaluate this effect?. Eur J Clin Pharmacol 40, S77–S80 (1991). https://doi.org/10.1007/BF01409414
Issue Date:
DOI: https://doi.org/10.1007/BF01409414